Moderna Inc. Stock Climbs 5.6%, Outperforms Peers
Dow Jones2026/09/22 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. advanced 5.6% to $182.56 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.5% to 27,244.28 and the Dow Jones Industrial Average falling 0.4% to 51,863.69.
This was the stock's second consecutive day of gains.
Moderna Inc. hit a new 52-week high, surpassing its previous peak of $176.86, which the company achieved on September 21st.
The stock outperformed some of its peers, as Johnson & Johnson fell 0.1% to $269.19, Pfizer Inc. rose 0.7% to $27.93, and Gilead Sciences Inc. rose 1.40% to $152.67.
Trading volume totaled 23.7 million, compared to the 50-day average of 18.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 22, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Honda Motor (HMC.US) Reports 65.7% Increase in Net Profit in the First Half, Plans to Expand Production Capacity in North America and Brazil
Honda Motor (HMC.US) released its financial results for the first half of fiscal year 2027 on November 10.
Crypto winter not over? Mining rig hosting provider Bitari cancels orders at the last minute, IPO plans put on hold
Bitcoin mining service provider Bitari has withdrawn its Nasdaq IPO plan. The company originally intended to issue 4.3 million shares at $7 per share to raise $30 million. Its annual revenue is approximately $11 million.

Pre-orders for GTA 6 are booming and may reverse the downward trend! Citigroup raises Take-Two Interactive Software (TTWO.US) target to $270
Citigroup maintains a "Buy" rating on Take-Two Interactive Software, with a target price of $270.